Skip to main content

BASES MOLECULARES DEL PLEGAMIENTO Y CITOTOXICIDAD DE LAS RIBONUCLEASAS PANCREATICAS. EVALUACION DE LA ACTIVIDAD CITOTOXICA Y DISEÑO DE ESTRATEGIAS PARA SU CONTROL MEDIANTE SPLICING PROTEICO.

BFU2009-06935

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2009
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Proyectos de Investigación
Beneficiary centre UNIVERSITAT DE GIRONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Generation of new cytotoxic human ribonuclease variants directed to the nucleus

  • Vert Company, Anna
  • Castro Gallegos, Jessica
  • Ruiz Martínez, Santiago
  • Tubert Juhé, Pere
  • Escribano, Diego
  • Ribó i Panosa, Marc
  • Vilanova i Brugués, Maria
  • Benito i Mundet, Antoni
Ribonucleases are promising agents for use in anticancer therapy. Engineering a nuclear localization signal into the sequence of the human pancreatic ribonuclease has been revealed as a new strategy to endow this enzyme with cytotoxic activity against tumor cells. We previously described a cytotoxic human pancreatic ribonuclease variant, named PE5, which is able to cleave nuclear RNA, inducing the apoptosis of cancer cells and reducing the amount of P-glycoprotein in different multidrug-resistant cell lines. These results open the opportunity to use this ribonuclease in combination with other chemotherapeutics. In this work, we have investigated how to improve the properties of PE5 as an antitumor drug candidate. When attempting to develop a recombinant protein as a drug, two of the main desirable attributes are minimum immunogenicity and maximum potency. The improvements of PE5 have been designed in both senses. First, in order to reduce the potential immunogenicity of the protein, we have studied which residues mutated on PE5 can be reverted to those of the wild-type human pancreatic ribonuclease sequence without affecting its cytotoxicity. Second, we have investigated the effect of introducing an additional nuclear localization signal at different sites of PE5 in an effort to obtain a more cytotoxic enzyme. We show that the nuclear localization signal location is critical for the cytotoxicity. One of these variants, named NLSPE5, presents about a 10-fold increase in cytotoxicity respective to PE5. This variant induces apoptosis and kills the cells using the same mechanism as PE5, This work has been supported by Grant BFU2009-06935 from MICINN (Spain) and by Grant GRCT04 from the University of Girona. We are very grateful to Dr. Milica Pesic and Dr. Sabera Ruzdijićfor providing us with the NCI-H460/R cell line and to Dr. Ramon Colomer for providing us with the NCI/ ADR-RES cell line. A.V., J.C., and P.T. acknowledge their fellowship from MINEDU, Universitat de Girona, and MEC (Spain), respectively
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells

  • Vert Company, Anna
  • Castro Gallegos, Jessica
  • Ribó i Panosa, Marc
  • Benito i Mundet, Antoni
  • Vilanova i Brugués, Maria
Ribonucleases represent a new class of antitumor RNA-damaging drugs. However, many wild-type members of the vertebrate secreted ribonuclease family are not cytotoxic because they are not able to evade the cytosolic ribonuclease inhibitor. We previously engineered the human pancreatic ribonuclease to direct it to the cell nucleus where the inhibitor is not present. The best characterized variant is PE5 that kills cancer cells through apoptosis mediated by the p21WAF1/CIP1 induction and the inactivation of JNK. Here, we have used microarray-derived transcriptional profiling to identify PE5 regulated genes on the NCI/ADR-RES ovarian cancer cell line. RT-qPCR analyses have confirmed the expression microarray findings. The results show that PE5 cause pleiotropic effects. Among them, it is remarkable the down-regulation of multiple genes that code for enzymes involved in deregulated metabolic pathways in cancer cells, This work has been supported by grants BFU2009-06935 and BIO2013-43517 from MINECO (Spain) and SING12/0 from UdG (Spain).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Structural investigation of ribonuclease A conformational preferences using high pressure protein crystallography

  • Kurpiewska, Katarzyna
  • Dziubek, Kamil
  • Katrusiak, Andrzej
  • Font i Sadurní, Josep
  • Ribó i Panosa, Marc
  • Vilanova i Brugués, Maria
  • Lewiński, Krzysztof
Hydrostatic pressure in range 0.1-1.5 GPa is used to modify biological system behaviour mostly in biophysical studies of proteins in solution. Due to specific influence on the system equilibrium high pressure can act as a filter that enables to identify and investigate higher energy protein conformers. The idea of the presented experiments is to examine the behaviour of RNase A molecule under high pressure before and after introduction of destabilizing mutation. For the first time crystal structures of wild-type bovine pancreatic ribonuclease A and its markedly less stable variant modified at position Ile106 were determined at different pressures. X-ray diffraction experiments at high pressure showed that the secondary structure of RNase A is well preserved even beyond 0.67 GPa at room temperature. Detailed structural analysis of ribonuclease A conformation observed under high pressure revealed that pressure influences hydrogen bonds pattern, cavity size and packing of molecule, This work has been supported by Grants BFU2009-06935 and BIO2013-43517 from MINECO (Spain)
Recercat. Dipósit de la Recerca de Catalunya
Publication Capítulo o parte de un libro (BookPart)

Antitumor Ribonucleases

  • Ribó i Panosa, Marc
  • Benito i Mundet, Antoni
  • Vilanova i Brugués, Maria
Ribonucleases are small basic proteins that have shown remarkable antitumor activity linked to their ability to destroy RNA. Therefore, they are a second line of cancer chemotherapeutics as they are not genotoxic. This chapter summarizes the main biochemical characteristics of these enzymes and the key factors responsible for their cytotoxic mechanism. Some of them are shared by most cytotoxins, but each RNase has particular cancer cell killing abilities. The effects on the cell cycle and the induced apoptosis mechanism are cell dependent. The knowledge obtained from the cytotoxic mechanism of natural cytotoxic RNases has been used to artificially engineer more potent and selective RNA-degrading enzymes. These approaches are also described. The chapter ends with a brief description of the results of the clinical trials performed with RNases, This work has been supported by grants BFU2009-06935 from MICINN (Spain) and GRCT04 from the University of Girona
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

1H, 13C and 15N resonance assignments of the Onconase FL-G zymogen

  • Serrano, Soraya
  • Callís Figueres, Mariona
  • Vilanova i Brugués, Maria
  • Benito i Mundet, Antoni
  • Laurents, Douglas V.
  • Ribó i Panosa, Marc
  • Bruix, Marta
Onconase® FL-G zymogen is a 120 residue protein produced by circular permutation of the native Onconase® sequence. In this construction, the wild type N- and C-termini are linked by a 16 residue segment and new N- and C-termini are generated at wild type positions R73 and S72. This novel segment linking the native N- and C-termini is designed to obstruct Onconase's® active site and encloses a cleavage site for the HIV-1 protease. As a first step towards the resolution of its 3D structure and the study of its structure-function relationships, we report here the nearly complete NMR 1H, 13C and 15N resonance chemical shift assignments at pH 5.2 and 35 C (BMRB deposit no 17973). The results presented here clearly show that the structure of the wild type Onconase ® is conserved in the FL-G zymogen, This work was supported by the projects, CTQ2008-0080, CTQ2010-21567-C02-02 and BFU2009-06935/ BMC from MICINN and PUG2008A from the Universitat de Girona
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Investigating the Effects of Double Mutation C30A/C75A on Onconase Structure: Studies at Atomic Resolution

  • Kurpiewska, Katarzyna
  • Torrent Alberti, Gerard
  • Ribó i Panosa, Marc
  • Loch, Joanna I.
  • Vilanova i Brugués, Maria
  • Lewiński, Krzysztof
The structure of onconase C30A/C75A double mutant has been determined at 1.12A° resolution. The structure has high structural homology to other onconase structures. The changes being results of mutation are relatively small, distributed asymmetrically around the two mutated positions, and they are observed not only in the mutation region but expanded to entire molecule. Different conformation of Lys31 side chain that influences the hydrogen bonding network around catalytic triad is probably responsible for lower catalytic efficiency of double mutant. The decrease in thermal stability observed for the onconase variant might be explained by a less dense packing as manifested by the increase of the molecular volume and the solvent accessible surface area